Defective neuromuscular junction organization and postnatal myogenesis in mice with severe spinal muscular atrophy.
paper
Cited
Public
Unavailable
- Authors
- Dachs, Elisabet; Hereu, Marta; Piedrafita, LΓdia; Casanovas, Anna; CalderΓ³, Jordi; Esquerda, Josep E
- Year
- 2011
- Journal
- Journal of neuropathology and experimental neurology
- PMID
- 21572339
- DOI
- 10.1097/NEN.0b013e31821cbd8b
A detailed pathologic analysis was performed on Smn(-/-);SMN2 mice as a mouse model for human type I spinal muscular atrophy (SMA). We provide new data concerning changes in the spinal cord, neuromuscular junctions and muscle cells, and in the organs of the immune system. The expression of 10 synaptic proteins was analyzed in 3-dimensionally reconstructed neuromuscular junctions by confocal microscopy. In addition to defects in postsynaptic occupancy, there was a marked reduction in calcitonin gene-related peptide and Rab3A in the presynaptic motor terminals of some, but not all, of the skeletal muscles analyzed. Defects in the organization of presynaptic nerve terminals were also detected by electron microscopy. Moreover, degenerative changes in muscle cells, defective postnatal muscle growth, and prominent muscle satellite cell apoptosis were also observed. All of these changes occurred in the absence of massive loss of spinal cord motoneurons. On the other hand, astroglia, but not microglia, increased in the ventral horn of newborn SMA mice. In skeletal muscles, the density of interstitial macrophages was significantly reduced, and monocyte chemotactic protein-1 was downregulated. These findings raise questions regarding the primary contribution of a muscle cell defect to the SMA phenotype.
No figures extracted from this document.
No chunks β full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
No citations found.
In this knowledge base
| Title | Year | PMID |
|---|---|---|
| Copy number variations in 6q14.1 and 5q13.2 are associated with alcohol dependence. | 2012 | 22702843 |
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Decoding inflammatory pathways in spinal muscular atrophy: implications for next-generation therapies. | Ottoboni L et al. | β | 2026 | β |
| Lymphoid Organ Architecture and Hematopoiesis Disruption in Spinal Muscular Atrophy: Therapeutic Rescue by SMN Restoration. | GuillamΓ³n P et al. | β | 2026 | β |
| Skeletal muscle in spinal muscular atrophy: Critical insights from pathogenesis to therapeutic strategies. | Ottoboni L et al. | β | 2026 | β |
| Versatile role of fibro-adipogenic progenitors in neuromuscular junction homeostasis and pathology. | Li R et al. | β | 2026 | β |
| Drug Candidate BIO101 for Spinal Muscular Atrophy as Monotherapy or Combined With the Antisense Oligonucleotide ASO-10-27. | BΓ©zier C et al. | β | 2025 | β |
| Glial Cells in Spinal Muscular Atrophy: Speculations on Non-Cell-Autonomous Mechanisms and Therapeutic Implications. | BelanΔiΔ A et al. | β | 2025 | β |
| Is TREM2 a Stretch: Implications of TREM2 Along Spinal Cord Circuits in Health, Aging, Injury, and Disease. | Pottorf TS et al. | β | 2025 | β |
| Macrophage induces angiogenesis via HIF signaling in denervated muscle following nerve injury. | Sato-Yamada Y et al. | β | 2025 | β |
| Unraveling the role of CGRP in neurological diseases: a comprehensive exploration to pathological mechanisms and therapeutic implications. | Sarkar S et al. | β | 2025 | β |
| Six-minute walk test as outcome measure of fatigability in adults with spinal muscular atrophy treated with nusinersen. | Govoni A et al. | β | 2024 | β |
| SMN Deficiency Induces an Early Non-Atrophic Myopathy with Alterations in the Contractile and Excitatory Coupling Machinery of Skeletal Myofibers in the SMNβ7 Mouse Model of Spinal Muscular Atrophy. | Berciano MT et al. | β | 2024 | β |
| What could be the function of the spinal muscular atrophy-causing protein SMN in macrophages? | Tapken I et al. | β | 2024 | β |
| DOK7 Promotes NMJ Regeneration After Nerve Injury. | Kosco ED et al. | β | 2023 | β |
| Dysregulation of Aldh1a2 underlies motor neuron degeneration in spinal muscular atrophy. | Kataoka M et al. | β | 2023 | β |
| A novel CARM1-HuR axis involved in muscle differentiation and plasticity misregulated in spinal muscular atrophy. | Ravel-Chapuis A et al. | β | 2022 | β |
| Effect of chronic intermittent hypoxia (CIH) on neuromuscular junctions and mitochondria in slow- and fast-twitch skeletal muscles of mice-the role of iNOS. | Bannow LI et al. | β | 2022 | β |
| Mouse models of SMA show divergent patterns of neuronal vulnerability and resilience. | Woschitz V et al. | β | 2022 | β |
| Premature delivery in the domestic sow in response to in utero delivery of AAV9 to fetal piglets. | Rich KA et al. | β | 2022 | β |
| SMN Is Physiologically Downregulated at Wild-Type Motor Nerve Terminals but Aggregates Together with Neurofilaments in SMA Mouse Models. | Franco-Espin J et al. | β | 2022 | β |
| Suppression of the necroptotic cell death pathways improves survival in <i>Smn</i> <sup>2<i>B</i>/-</sup> mice. | Chehade L et al. | β | 2022 | β |
| AAV1.NT-3 gene therapy in a CMT2D model: phenotypic improvements in <i>Gars<sup>P278KY/+</sup></i> mice. | Ozes B et al. | β | 2021 | β |
| Activation of Muscle-Specific Kinase (MuSK) Reduces Neuromuscular Defects in the Delta7 Mouse Model of Spinal Muscular Atrophy (SMA). | Feng Z et al. | β | 2021 | β |
| Macrophage roles in peripheral nervous system injury and pathology: Allies in neuromuscular junction recovery. | Rios R et al. | β | 2021 | β |
| Spinal muscular atrophy: Broad disease spectrum and sex-specific phenotypes. | Singh NN et al. | β | 2021 | β |
| Glial cells involvement in spinal muscular atrophy: Could SMA be a neuroinflammatory disease? | Abati E et al. | β | 2020 | β |
| A circuit-dependent ROS feedback loop mediates glutamate excitotoxicity to sculpt the <i>Drosophila</i> motor system. | Peng JJ et al. | β | 2019 | β |
| Glial Activation and Central Synapse Loss, but Not Motoneuron Degeneration, Are Prevented by the Sigma-1 Receptor Agonist PRE-084 in the Smn2B/- Mouse Model of Spinal Muscular Atrophy. | CerverΓ³ C et al. | β | 2018 | β |
| Imaging Analysis of the Neuromuscular Junction in Dystrophic Muscle. | Pratt SJP et al. | β | 2018 | β |
| Pathogenic commonalities between spinal muscular atrophy and amyotrophic lateral sclerosis: Converging roads to therapeutic development. | Bowerman M et al. | β | 2018 | β |
| The role of survival motor neuron protein (SMN) in protein homeostasis. | Chaytow H et al. | β | 2018 | β |
| Immune dysregulation may contribute to disease pathogenesis in spinal muscular atrophy mice. | Deguise MO et al. | β | 2017 | β |
| Immunohistochemical analysis of canine and feline muscle disorders using formalin-fixed, paraffin-embedded tissues. | Shiga T et al. | β | 2017 | β |
| New insights into SMA pathogenesis: immune dysfunction and neuroinflammation. | Deguise MO et al. | β | 2017 | β |
| SMN deficiency negatively impacts red pulp macrophages and spleen development in mouse models of spinal muscular atrophy. | Khairallah MT et al. | β | 2017 | β |
| Survival of motor neurone protein is required for normal postnatal development of the spleen. | Thomson AK et al. | β | 2017 | β |
| Central and peripheral defects in motor units of the diaphragm of spinal muscular atrophy mice. | Neve A et al. | β | 2016 | β |
| Chronic Treatment with the AMPK Agonist AICAR Prevents Skeletal Muscle Pathology but Fails to Improve Clinical Outcome in a Mouse Model of Severe Spinal Muscular Atrophy. | CerverΓ³ C et al. | β | 2016 | β |
| Critical role of miRNAs in mediating skeletal muscle atrophy (Review). | Yu Y et al. | β | 2016 | β |
| Is spinal muscular atrophy a disease of the motor neurons only: pathogenesis and therapeutic implications? | Simone C et al. | β | 2016 | β |
| Neuroprotective Effect of Non-viral Gene Therapy Treatment Based on Tetanus Toxin C-fragment in a Severe Mouse Model of Spinal Muscular Atrophy. | OlivΓ‘n S et al. | β | 2016 | β |
| SMN deficiency does not induce oxidative stress in SMA iPSC-derived astrocytes or motor neurons. | Patitucci TN et al. | β | 2016 | β |
| Survival Motor Neuron (SMN) protein is required for normal mouse liver development. | Szunyogova E et al. | β | 2016 | β |
| Astrocytes influence the severity of spinal muscular atrophy. | Rindt H et al. | β | 2015 | β |
| Mechanistic principles of antisense targets for the treatment of spinal muscular atrophy. | Singh NN et al. | β | 2015 | β |
| Pre- and postsynaptic changes in the neuromuscular junction in dystrophic mice. | Pratt SJP et al. | β | 2015 | β |
| Spinal muscular atrophy: from tissue specificity to therapeutic strategies. | Iascone DM et al. | β | 2015 | β |
| Transcriptional profiling of differentially vulnerable motor neurons at pre-symptomatic stage in the Smn (2b/-) mouse model of spinal muscular atrophy. | Murray LM et al. | β | 2015 | β |
| Abnormalities in early markers of muscle involvement support a delay in myogenesis in spinal muscular atrophy. | MartΓnez-HernΓ‘ndez R et al. | β | 2014 | β |
| ALS-related misfolded protein management in motor neurons and muscle cells. | Galbiati M et al. | β | 2014 | β |
| Mechanisms involved in spinal cord central synapse loss in a mouse model of spinal muscular atrophy. | Tarabal O et al. | β | 2014 | β |
| Morphological analysis of neuromuscular junction development and degeneration in rodent lumbrical muscles. | Sleigh JN et al. | β | 2014 | β |
| Myogenic program dysregulation is contributory to disease pathogenesis in spinal muscular atrophy. | Boyer JG et al. | β | 2014 | β |
| Skeletal muscle DNA damage precedes spinal motor neuron DNA damage in a mouse model of Spinal Muscular Atrophy (SMA). | Fayzullina S et al. | β | 2014 | β |
| Splicing changes in SMA mouse motoneurons and SMN-depleted neuroblastoma cells: evidence for involvement of splicing regulatory proteins. | Huo Q et al. | β | 2014 | β |
| The craniosacral progression of muscle development influences the emergence of neuromuscular junction alterations in a severe murine model for spinal muscular atrophy. | Voigt T et al. | β | 2014 | β |
| The lack of CuZnSOD leads to impaired neurotransmitter release, neuromuscular junction destabilization and reduced muscle strength in mice. | Shi Y et al. | β | 2014 | β |
| Chronic treatment with lithium does not improve neuromuscular phenotype in a mouse model of severe spinal muscular atrophy. | Dachs E et al. | β | 2013 | β |
| Defects in neuromuscular junction remodelling in the Smn(2B/-) mouse model of spinal muscular atrophy. | Murray LM et al. | β | 2013 | β |
| Early onset muscle weakness and disruption of muscle proteins in mouse models of spinal muscular atrophy. | Boyer JG et al. | β | 2013 | β |
| Genome-wide analysis shows association of epigenetic changes in regulators of Rab and Rho GTPases with spinal muscular atrophy severity. | Zheleznyakova GY et al. | β | 2013 | β |
| Identification of RNA bound to the TDP-43 ribonucleoprotein complex in the adult mouse brain. | Narayanan RK et al. | β | 2013 | β |
| More than a bystander: the contributions of intrinsic skeletal muscle defects in motor neuron diseases. | Boyer JG et al. | β | 2013 | β |
| Notch signaling pathway is activated in motoneurons of spinal muscular atrophy. | Caraballo-Miralles V et al. | β | 2013 | β |
| Spinal muscular atrophy astrocytes exhibit abnormal calcium regulation and reduced growth factor production. | McGivern JV et al. | β | 2013 | β |
| Spinal muscular atrophy: new findings for an old pathology. | Bottai D et al. | β | 2013 | β |
| Synaptic defects in type I spinal muscular atrophy in human development. | MartΓnez-HernΓ‘ndez R et al. | β | 2013 | β |
| The DcpS inhibitor RG3039 improves motor function in SMA mice. | Van Meerbeke JP et al. | β | 2013 | β |
| Behavioral and electrophysiological outcomes of tissue-specific Smn knockdown in Drosophila melanogaster. | Timmerman C et al. | β | 2012 | β |
| Copy number variations in 6q14.1 and 5q13.2 are associated with alcohol dependence. | Lin P et al. | β | 2012 | β |
| Neurofilament Phosphorylation during Development and Disease: Which Came First, the Phosphorylation or the Accumulation? | Dale JM et al. | β | 2012 | β |
| Neurogenic and myogenic contributions to hereditary motor neuron disease. | Bricceno KV et al. | β | 2012 | β |
| Survival motor neuron protein in motor neurons determines synaptic integrity in spinal muscular atrophy. | Martinez TL et al. | β | 2012 | β |
| Reversible molecular pathology of skeletal muscle in spinal muscular atrophy. | Mutsaers CA et al. | β | 2011 | β |